India needs to establish a sufficiently large installed capacity of nuclear power by fast breeders if it has to sustain nuclear power for longer period.
The markets breadth was negative - out of 2,717 stocks traded, 1,804 declined, 842 advanced and 71 were unchanged on Thursday. The index moved in a range of 207 points between 15,052 (low) and 15,259 (high).
The Reliance Anil Dhirubhai Ambani Group on Wednesday threatened to sue three top officials of Mukesh Ambani's Reliance Industries for breach of trust and their inability to protect the interest of shareholders of an ADAG company.
India on Wednesday signed a bilateral investment promotion and protection agreement with Syria, and is in the process of signing similar pacts with a host of countries.
The Securities and Exchange Board of India is looking into the possibility of price manipulation in the shares of Ranbaxy Laboratories. Sources familiar with the developments said a couple of market intermediaries may find the going tough, with the market
India has shipped close to 85 million mobile handsets between April 2007 and March 2008, compared to under 66 million units shipped in the previous fiscal, registering an year-on-year growth of around 29 per cent.
The Bombay Stock Exchange is set to see a reshuffle in its board of directors, the first since the country's oldest bourse was demutualised and became a limited company last year. The reshuffle, details of which are yet to be
With the objective of increasing its presence in China, Indian software training company NIIT has signed a memorandum of understanding with Chinese real estate developer Shui On to set up training operations in at its upcoming Dalian Tiandi Software Hub.
Confronted with spiralling aviation turbine fuel prices, which account for half an airline's operating costs in India, several low-cost and full-service carriers will go for a steep increase in fares that could vary from 5 to 20 per cent, from
Shares of Ranbaxy Laboratories on Thursday fell 7.67 per cent on the Bombay Stock Exchange to Rs 552.25 at close, after top investment banks like JP Morgan and CLSA said the out-of-court settlement with Pfizer over cholesterol pill Lipitor announced